John Priya, Lazarus Flemingson, George Joann Pauline, Selvam Arul, Prabhuji Munivenkatappa Lakshmaiah Venkatesh
Senior Lecturer, Mar Baselious Dental College , Kothamangalam, Kerala, India.
Former Professor and HOD, Department of Periodontology, Best Dental College , Madurai, India .
J Clin Diagn Res. 2015 May;9(5):ZC70-4. doi: 10.7860/JCDR/2015/11534.5965. Epub 2015 May 1.
PerioChip a bovine origin gelatine based CHX chip has shown beneficial effects in the management of Chronic Periodontitis. A new fish collagen based CHX chip similar to PerioChip is currently available; however this product has not been thoroughly researched.
The aim of the present study was to evaluate the effectiveness of a new Piscean collagen-based controlled-release chlorhexidine chip (CHX chip) as an adjunctive therapy to scaling and root planing (SRP).
The study was conducted as a randomised, split-mouth, controlled clinical trial at Krishnadevaraya College of Dental Sciences, Bangalore, India.
In a split-mouth study involving 20 sites in 10 patients with chronic periodontitis, control sites received scaling and root planing and test sites received scaling and root planing (SRP) and the intrapocket CHX chip placement as an adjunct. Subgingival plaque samples were collected from both control and test sites at baseline, 11 days and 11 weeks and the anaerobic colony count were assessed. Clinical parameters that were recorded at baseline and 11 weeks were gingival index, Plaque index, Probing pocket depth (PPD), and Clinical attachment level (CAL). Plaque index was recorded additionally at 11 days.
In the test group there was a statistically significant reduction in the total anaerobic colony count, gingival index and plaque scores from baseline as compared to control sites at all time intervals. An additional 0.8mm reduction in mean probing pocket depth was noted in the test group. Gain in Clinical attachment level was comparable in both groups.
The adjunctive use of the new collagen-based CHX chip yielded significant antimicrobial benefit accompanied by a reduction in probing depth and a clinical attachment level gain as compared to SRP alone. This suggests that it may be a useful treatment option of nonsurgical periodontal treatment of chronic periodontitis.
PerioChip是一种基于牛源明胶的洗必泰芯片,已显示出在慢性牙周炎治疗中具有有益效果。目前有一种类似PerioChip的新型鱼胶原蛋白基洗必泰芯片;然而,该产品尚未得到充分研究。
本研究的目的是评估一种新型鱼胶原蛋白基控释洗必泰芯片(洗必泰芯片)作为龈下刮治和根面平整(SRP)辅助治疗的有效性。
该研究在印度班加罗尔的克里希纳德瓦拉亚牙科学院进行,为随机、双侧、对照临床试验。
在一项涉及10例慢性牙周炎患者20个部位的双侧研究中,对照部位接受龈下刮治和根面平整,试验部位接受龈下刮治和根面平整(SRP)并在袋内放置洗必泰芯片作为辅助治疗。在基线、11天和11周时从对照和试验部位采集龈下菌斑样本,并评估厌氧菌落计数。在基线和11周时记录的临床参数有牙龈指数、菌斑指数、探诊深度(PPD)和临床附着水平(CAL)。在11天时额外记录菌斑指数。
在试验组中,与对照部位相比,在所有时间间隔内,总厌氧菌落计数、牙龈指数和菌斑评分从基线时有统计学显著降低。试验组平均探诊深度额外减少了0.8mm。两组的临床附着水平增加相当。
与单独的SRP相比,新型胶原蛋白基洗必泰芯片的辅助使用产生了显著的抗菌益处,同时探诊深度降低且临床附着水平增加。这表明它可能是慢性牙周炎非手术牙周治疗的一种有用治疗选择。